Lanifibranor is a pan-peroxisome proliferator-activated receptor (PPAR) agonist and is the first medication that targets PPAR-alpha, PPAR-beta, and PPAR-gamma simultaneously.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.